Bach Ardalan

2.4k total citations
105 papers, 1.9k citations indexed

About

Bach Ardalan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bach Ardalan has authored 105 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 40 papers in Molecular Biology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bach Ardalan's work include Colorectal Cancer Treatments and Studies (31 papers), Gastric Cancer Management and Outcomes (18 papers) and Biochemical and Molecular Research (17 papers). Bach Ardalan is often cited by papers focused on Colorectal Cancer Treatments and Studies (31 papers), Gastric Cancer Management and Outcomes (18 papers) and Biochemical and Molecular Research (17 papers). Bach Ardalan collaborates with scholars based in United States, Chile and United Kingdom. Bach Ardalan's co-authors include Pochi R. Subbarayan, Robert I. Glazer, Howard Silberman, Alan S. Livingstone, Thomas R. Fleming, Hiremagalur N. Jayaram, James H. Doroshow, Cynthia G. Leichman, Randall F. Holcombe and Geoffrey R. Weiss and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Bach Ardalan

100 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bach Ardalan United States 22 1.1k 601 453 311 247 105 1.9k
André Planting Netherlands 31 1.6k 1.4× 923 1.5× 720 1.6× 362 1.2× 196 0.8× 71 2.6k
M Forni France 19 1.1k 1.0× 526 0.9× 458 1.0× 299 1.0× 182 0.7× 39 1.8k
N. Renée France 23 2.0k 1.8× 752 1.3× 622 1.4× 243 0.8× 483 2.0× 65 2.6k
Rakesh Goel Canada 20 790 0.7× 376 0.6× 287 0.6× 248 0.8× 244 1.0× 95 1.5k
M C Etienne France 27 2.1k 1.9× 859 1.4× 598 1.3× 276 0.9× 383 1.6× 54 2.8k
W P Tong United States 19 1.1k 1.0× 506 0.8× 421 0.9× 339 1.1× 118 0.5× 31 1.8k
Lindsey Gumbrell United Kingdom 17 1.3k 1.1× 932 1.6× 564 1.2× 392 1.3× 549 2.2× 24 2.7k
Christine M. Walko United States 24 992 0.9× 473 0.8× 454 1.0× 236 0.8× 235 1.0× 84 2.0k
D. Machover France 22 1.5k 1.3× 436 0.7× 616 1.4× 335 1.1× 446 1.8× 85 2.3k
Chueh‐Chuan Yen Taiwan 23 1.2k 1.0× 541 0.9× 708 1.6× 821 2.6× 204 0.8× 57 2.3k

Countries citing papers authored by Bach Ardalan

Since Specialization
Citations

This map shows the geographic impact of Bach Ardalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bach Ardalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bach Ardalan more than expected).

Fields of papers citing papers by Bach Ardalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bach Ardalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bach Ardalan. The network helps show where Bach Ardalan may publish in the future.

Co-authorship network of co-authors of Bach Ardalan

This figure shows the co-authorship network connecting the top 25 collaborators of Bach Ardalan. A scholar is included among the top collaborators of Bach Ardalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bach Ardalan. Bach Ardalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ardalan, Bach, Yasmine Baca, Andrew Hinton, et al.. (2025). Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma. Clinical Cancer Research. 31(6). 1082–1090. 5 indexed citations
2.
3.
4.
Subbarayan, Pochi R. & Bach Ardalan. (2014). In the War Against Solid Tumors Arsenic Trioxide Need Partners. Journal of Gastrointestinal Cancer. 45(3). 363–371. 48 indexed citations
5.
Subbarayan, Pochi R., Malancha Sarkar, Pradeep Kumar, et al.. (2012). Achyranthes aspera (Apamarg) leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosis. Journal of Ethnopharmacology. 142(2). 523–530. 16 indexed citations
6.
Subbarayan, Pochi R., Kelvin H. Lee, & Bach Ardalan. (2010). Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.. PubMed. 30(4). 1157–62. 27 indexed citations
7.
Subbarayan, Pochi R., Malancha Sarkar, Stefania Impellizzeri, et al.. (2010). Anti-proliferative and anti-cancer properties of Achyranthes aspera: Specific inhibitory activity against pancreatic cancer cells. Journal of Ethnopharmacology. 131(1). 78–82. 34 indexed citations
8.
Subbarayan, Pochi R., et al.. (2010). Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.. PubMed. 30(4). 1149–56. 18 indexed citations
9.
10.
Ribeiro, Afonso, et al.. (2006). Endoscopic Ultrasound Restaging After Neoadjuvant Chemotherapy in Esophageal Cancer. The American Journal of Gastroenterology. 101(6). 1216–1221. 35 indexed citations
11.
Moore, M. R., Graydon Harker, Bach Ardalan, et al.. (2006). Phase II trial of DJ-927, an oral tubulin depolymerization inhibitor, in the treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 24(18_suppl). 3591–3591. 11 indexed citations
12.
Subbarayan, Pochi R., et al.. (2005). Inhibition of RNA synthesis by 5-fluorouridine accounts for its cyto toxicity on colorectal cancer cells in vitro. Cancer Research. 65. 317–318. 1 indexed citations
13.
Steïner, G., et al.. (1998). D4/5-HT2A Receptor antagonists: LU-111995 and other potential new antipsychotics in development. Drugs of the Future. 23(2). 191–191. 18 indexed citations
14.
Moffat, Frederick L., Aldo N. Serafini, V. Javier Casillas, et al.. (1994). Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled fab′ fragments of the immu-4 anti-carcinoembryonic antigen monoclonal antibody. Cancer. 73(S3). 836–845. 21 indexed citations
15.
Ardalan, Bach, K. Rajender Reddy, Pasquale Benedetto, et al.. (1992). Phase I study of high dose 5-fluorouracil and high dose leucovorin with low dose phosphonacetyl-l-aspartic acid in patients with advanced malignancies. International Journal of Radiation Oncology*Biology*Physics. 22(3). 511–514. 17 indexed citations
16.
Ardalan, Bach, K. S. Sridhar, Pasquale Benedetto, et al.. (1991). A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies. Cancer. 68(6). 1242–1246. 12 indexed citations
17.
Spicer, Darcy, Bach Ardalan, John R. Daniels, Howard Silberman, & Kay Johnson. (1988). Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics.. PubMed. 48(2). 459–61. 36 indexed citations
18.
Ardalan, Bach, et al.. (1988). Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines. Cancer Chemotherapy and Pharmacology. 22(3). 191–196. 5 indexed citations
19.
McGovren, J. Patrick, Robert J. Belt, Sarah A. Taylor, et al.. (1985). Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.. PubMed. 45(9). 4460–3. 10 indexed citations
20.
Ardalan, Bach, David A. Cooney, Hiremagalur N. Jayaram, et al.. (1980). Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.. PubMed. 40(5). 1431–7. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Planting Breakdown of academic impact, for papers by M Forni Breakdown of academic impact, for papers by N. Renée Breakdown of academic impact, for papers by Rakesh Goel Breakdown of academic impact, for papers by M C Etienne Breakdown of academic impact, for papers by W P Tong Breakdown of academic impact, for papers by Lindsey Gumbrell Breakdown of academic impact, for papers by Christine M. Walko Breakdown of academic impact, for papers by D. Machover Breakdown of academic impact, for papers by Chueh‐Chuan Yen
Rankless by CCL
2026